Welcome to LookChem.com Sign In|Join Free

CAS

  • or

60617-83-6

(3beta,5beta,17xi)-3-[(3-carboxypropanoyl)oxy]-14-hydroxybufa-20,22-dienolide is a complex steroid compound belonging to the bufadienolide class, which are naturally occurring substances found in plants and animals. This particular compound features a carboxypropanoyl group at the 3-position, a hydroxy group at the 14-position, and a double bond between the 20th and 22nd positions. Its potential biological activities include anti-cancer, anti-inflammatory, and cardioactive properties, with specific effects and applications contingent upon further research and experimentation.

60617-83-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

  • 4-[[(3S,5R,8R,9S,10S,13R,14S)-14-hydroxy-10,13-dimethyl-17-(6-oxopyran-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-oxo-butanoic acid

    Cas No: 60617-83-6

  • USD $ 3.0-3.0 / Kilogram

  • 1 Kilogram

  • 1-100 Metric Ton/Month

  • Dayang Chem (Hangzhou) Co.,Ltd.
  • Contact Supplier
  • 60617-83-6 Structure

  • Basic information

    1. Product Name: (3beta,5beta,17xi)-3-[(3-carboxypropanoyl)oxy]-14-hydroxybufa-20,22-dienolide
    2. Synonyms:
    3. CAS NO:60617-83-6
    4. Molecular Formula: C28H38O7
    5. Molecular Weight: 486.5971
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 60617-83-6.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 664.2°C at 760 mmHg
    3. Flash Point: 218.1°C
    4. Appearance: N/A
    5. Density: 1.27g/cm3
    6. Vapor Pressure: 1.79E-20mmHg at 25°C
    7. Refractive Index: 1.586
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: (3beta,5beta,17xi)-3-[(3-carboxypropanoyl)oxy]-14-hydroxybufa-20,22-dienolide(CAS DataBase Reference)
    11. NIST Chemistry Reference: (3beta,5beta,17xi)-3-[(3-carboxypropanoyl)oxy]-14-hydroxybufa-20,22-dienolide(60617-83-6)
    12. EPA Substance Registry System: (3beta,5beta,17xi)-3-[(3-carboxypropanoyl)oxy]-14-hydroxybufa-20,22-dienolide(60617-83-6)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 60617-83-6(Hazardous Substances Data)

60617-83-6 Usage

Uses

Used in Pharmaceutical Industry:
(3beta,5beta,17xi)-3-[(3-carboxypropanoyl)oxy]-14-hydroxybufa-20,22-dienolide is used as a pharmaceutical compound for its potential anti-cancer properties. Its complex molecular structure and bufadienolide class suggest that it may have significant biological activities, making it a candidate for further research and development in the fight against cancer.
Used in Research and Development:
In the field of scientific research, (3beta,5beta,17xi)-3-[(3-carboxypropanoyl)oxy]-14-hydroxybufa-20,22-dienolide is used as a subject of study for its potential anti-inflammatory and cardioactive properties. (3beta,5beta,17xi)-3-[(3-carboxypropanoyl)oxy]-14-hydroxybufa-20,22-dienolide's unique structure and the possibility of various biological activities make it an interesting target for researchers looking to understand its full potential and develop new therapeutic strategies.
Used in Drug Delivery Systems:
Similar to other bioactive compounds, (3beta,5beta,17xi)-3-[(3-carboxypropanoyl)oxy]-14-hydroxybufa-20,22-dienolide could be used in the development of drug delivery systems. These systems aim to improve the compound's bioavailability, targeting, and overall therapeutic efficacy, which could be particularly beneficial if the compound demonstrates potent anti-cancer or other medicinal properties upon further investigation.

Check Digit Verification of cas no

The CAS Registry Mumber 60617-83-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,0,6,1 and 7 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 60617-83:
(7*6)+(6*0)+(5*6)+(4*1)+(3*7)+(2*8)+(1*3)=116
116 % 10 = 6
So 60617-83-6 is a valid CAS Registry Number.

60617-83-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name Bufalin, 3-hemisuccinate

1.2 Other means of identification

Product number -
Other names bufalin 3-succinate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:60617-83-6 SDS

60617-83-6Downstream Products

60617-83-6Relevant articles and documents

Structure-cytotoxic activity relationship for the toad poison bufadienolides

Kamano, Yoshiaki,Kotake, Ayano,Hashima, Hirofumi,Inoue, Masuo,Morita, Hiroshi,Takeya, Koichi,Itokawa, Hideji,Nandachi, Nobuyo,Segawa, Toshiaki,Yukita, Ayako,Saitou, Kyoko,Katsuyama, Mariko,Pettit, George R.

, p. 1103 - 1115 (2007/10/03)

The toad poison bufadienolides including natural and derivatized compounds were tested for their cytotoxic effects on primary liver carcinoma cells PLC/PRF/5 and their structure-cytotoxic activity relationships were studied. For this study, a ligand-binding model was developed by using a pharmacophore mapping program, Distance Comparisons (DISCO). The structural features that are common to the 3D structures of active bufadienolides were identified to provide approach to a 3D QSAR method by using Comparative Molecular Field Analysis (CoMFA) study and to correlate the steric and electrostatic fields of the molecules to their activities. A valuable model which enables prediction of their activities was obtained from the CoMFA analysis, which may be employed for the drug designs of new bufadienolide analogues. Copyright (C) 1998 Elsevier Science Ltd.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 60617-83-6